Scientific ethics

フォロー

Spain's National Cancer Research Centre (CNIO) is reviewing whether scientist Mariano Barbacid violated its code of good practices by failing to disclose a conflict of interest in an article retracted by the US National Academy of Sciences. The paper, on a pancreatic cancer therapy tested in mice, was withdrawn because the authors did not declare their shares in Vega Oncotargets, the company set to commercialize the patent. Despite knowing since March, Barbacid did not inform the Cris Cancer Foundation, which raised 3.6 million euros in donations.

このウェブサイトはCookieを使用します

サイトを改善するための分析にCookieを使用します。詳細については、プライバシーポリシーをお読みください。
拒否